export const modernaText = {
  main: 'Moderna',
  sub: 'SARS-CoV-2 mRNA-1273',
  flavor: `The Moderna COVID‑19 vaccine, codenamed mRNA-1273, was a COVID‑19 vaccine developed by the United States National Institute of Allergy and Infectious Diseases, the Biomedical Advanced Research and Development Authority, and Moderna. It was administered by two 0.5 mL doses given by intramuscular injection given four weeks apart.\n\nIt was an RNA vaccine composed of nucleoside-modified mRNA encoding a spike protein of SARS-CoV-2, which was encapsulated in lipid nanoparticles. On 18 December 2020, mRNA-1273 was issued an Emergency Use Authorization by the United States Food and Drug Administration.`,
};

export const pfizerText = {
  main: 'Pfizer',
  sub: 'SARS-CoV-2 BNT162b2',
  flavor: `The Pfizer–BioNTech COVID‑19 vaccine was given by intramuscular injection. It was composed of nucleoside-modified mRNA encoding a mutated form of the spike protein of SARS-CoV-2, which was encapsulated in lipid nanoparticles. The vaccination required two doses given three weeks apart.\n\nIn December 2020, the United Kingdom was the first country to authorize the vaccine on an emergency basis, soon followed by the United States, the European Union and several other countries globally.`,
};
